Zug, Switzerland-based vVardis, a dental technology company, has closed on a $50 million funding round.
The funding round builds on the $35 million investment the company received from OrbiMed in February.
The funding will support the growth of the Curodont brand, vVardis’ drill-free tooth decay treatment, according to a July 15 news release.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
